TNF and splenic tuberculosis: This case emphasizes that splenic tuberculosis should remain in the differential diagnosis of patients receiving anti-tumor necrosis factor-α (TNF-α) agents, even after prior negative screening, and that early diagnosis via biopsy and rapid molecular testing (GeneXpert) significantly improves outcomes.